Zafgen, Inc. is a biopharmaceutical company focused on developing therapies for obesity and metabolic diseases. The company is engaged in the research and development of treatments aimed at addressing the underlying causes of these conditions. Zafgen operates primarily in the healthcare sector, targeting patients suffering from obesity and related metabolic disorders.
